In the partnership, Worldwide will serve as Every Cure’s clinical trial and drug development partner. The CRO will use its clinical development and rare disease expertise to assist in identifying links between rare diseases and generic drugs on the market...
Stay informed with the freshest Worldwide news & updates right from the source. Explore the latest developments in clinical research innovations.
Rare Disease Learn more Find the way forwardwith Worldwide Clinical Trials Transitioning a clinical trial can feel overwhelming, but it might be the best option to get your study back on track. See how we can help Discover why it’s a world of difference at Worldwide. ...
Clinical, technical and regulatory expertise to address the international regulatory, legal and strategic complexities of pediatric clinical development; Deep experience in conducting rare disease clinical trials, including the ability to access hard-to-find patient populations; Established connections with sit...
1.C.细节理解题.根据第一段Every year, around half a million children worldwide are born with a rare disease. Many patients with rare diseases go through lengthy trials and treatments until they are correctly diagnosed (诊断).每年,全世界大约有100万儿童出生时患有罕见疾病.许多罕见病患者经过漫长的...
Since July 2005,a pre-registration has been required for all clinical trials by a statement from ICMJE(the Internnational Committee of Medical Journal Editors).The purpose of pre-registration is to prevent the publication bias,to complete the ethical duty of physicians and to accelerate the enrollm...
The transformative power of AI in clinical trials Hannah Burke 24 Dec 24 Who are the top 10 medical device companies in the world in 2024? Hannah Burke 25 Oct 24 Proclinical named International Recruitment Company of the Year for the second year running Hannah Burke 03 Oct 24 US oncolo...
Conclusion: This registry provides a straightforward, no-cost mechanism for data sharing and contacting patients for clinical trials or research participation, which is important given the recruitment challenges for clinical trials for rare diseases. This is the first publication to present results from ...
Along its soaring trajectory Opdivo is expected to surpass Merck's ($MRK) Keytruda, also a PD-1 inhibitor which got its approval three months ahead of Opdivo. The two have been tracking neck and neck in approvals, and Merck has said it has more than 85 clinical trials underway across mor...
Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC) and Alzheimer’s Disease, today announced that it has signed a Master Services